Cymat Technologies Ltd.
CYMHF
$0.12
$0.000.00%
OTC PK
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 121.42% | 76.68% | 33.99% | -15.57% | -47.77% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 121.42% | 76.68% | 33.99% | -15.57% | -47.77% |
| Cost of Revenue | 54.70% | 8.69% | -13.96% | -27.49% | -40.44% |
| Gross Profit | 223.89% | 263.76% | 160.05% | 160.15% | -44.02% |
| SG&A Expenses | -20.93% | -28.75% | -29.81% | -34.52% | -37.04% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.39% | -11.23% | -21.26% | -29.75% | -37.78% |
| Operating Income | 38.25% | 53.40% | 44.95% | 38.41% | 32.27% |
| Income Before Tax | 23.21% | 39.09% | 35.73% | 33.00% | 31.09% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 23.21% | 39.09% | 35.73% | 33.00% | 31.09% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 23.21% | 39.09% | 35.73% | 33.00% | 31.09% |
| EBIT | 38.25% | 53.40% | 44.95% | 38.41% | 32.27% |
| EBITDA | 38.52% | 55.89% | 47.41% | 41.42% | 36.56% |
| EPS Basic | 27.05% | 42.93% | 41.25% | 37.87% | 36.27% |
| Normalized Basic EPS | 25.64% | 38.79% | 37.50% | 33.92% | 32.61% |
| EPS Diluted | 27.05% | 42.93% | 41.25% | 37.87% | 36.27% |
| Normalized Diluted EPS | 25.64% | 38.79% | 37.50% | 33.92% | 32.61% |
| Average Basic Shares Outstanding | 4.27% | 6.22% | 9.09% | 8.46% | 8.45% |
| Average Diluted Shares Outstanding | 4.27% | 6.22% | 9.09% | 8.46% | 8.45% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |